Powered by

Chutes & Ladders—GSK, Centessa part ways with Slaoui over sexual harassment allegations

Mar 26, 2021 - FierceBiotech
Board and Executive Moves

GlaxoSmithKline and Centessa Pharmaceuticals cut ties with Moncef Slaoui after an employee raised allegations of sexual harassment that occurred several years ago at GSK. AlloVir nabbed Gilead Sciences' virology lead Diana Brainard as its new CEO. Merck has tapped longtime insider Caroline Litchfield as chief financial officer.

Welcome to this week's Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. Please send the good word—or the bad—from your ...